Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q2 2016 · 10-Q
Revenue$71.14M$71.14M−1.4% vs Q2 2015 Net Income$3.40M$3.40M−45.6% vs Q2 2015 EPS Diluted$0.29$0.29−43.1% vs Q2 2015 Gross Profit$53,225,000+0.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$11,057,000+42.9% Free Cash Flowderived$10,387,000+42.8% Margins · derivedGross margin74.8%+1.1 pt vs Q2 2015
Operating margin7.1%−4.9 pt vs Q2 2015
Net margin4.8%−3.9 pt vs Q2 2015
ended Jun 30, 2016 · filed Aug 9, 2016 · 40 d after period end